BioNxt Solutions Inc.
BioNxt Solutions Inc.

Indice CSE:
Devise:
BioNxt Solutions Inc. is a bioscience accelerator focused on next-generation drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical production and evaluation, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization and clinical evaluation of emerging active pharmaceutical ingredients for neurological applications. The Company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets.
BioNxt Solutions Inc. (BNXT)
SEDAR Information
Information d'entreprise
Addresse
Royal Centre, 1055 West Georgia Street, Suite 1500
Vancouver, BC V6E 4N7
CanadaTéléphone
780-818-6422Courriel
info@bionxt.comDate d’inscription à la cote
Mercredi, juillet 31, 2019
Agent de transfert
Computershare Investor Services Inc.Capitalisation
Capitalisation:
115761754Réservé à l'émission:
16604110